Cabozantinib 3-Fluoro Impurity - Request Quote
Cabozantinib 3-Fluoro Impurity
| SZ CAT No: | SZ-C112028 |
| CAS No | NA |
| Mol.F. | C28H24FN3O5 |
| Mol.Wt. | 501.5 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cabozantinib 3-Fluoro Impurity is chemically N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(3-fluorophenyl)cyclopropane-1,1-dicarboxamide. Cabozantinib 3-Fluoro Impurity is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib 3-Fluoro Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabozantinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Cabozantinib 3-Fluoro Impurity
Purchase Cabozantinib 3-Fluoro Impurity
Cabozantinib 3-Fluoro Impurity suppliers
Cabozantinib 3-Fluoro Impurity manufacturers
Cabozantinib 3-Fluoro Impurity price
Order Cabozantinib 3-Fluoro Impurity
Enquire Cabozantinib 3-Fluoro Impurity
Cabozantinib 3-Fluoro Impurity cost
Cabozantinib 3-Fluoro Impurity Supplier
Cabozantinib 3-Fluoro Impurity Distributor
Cabozantinib 3-Fluoro Impurity for Method Validation
Cabozantinib Reference Standard
Cabozantinib 3-Fluoro Impurity for ANDA Filing
Cabozantinib 3-Fluoro Impurity for Forced Degradation Studies
Cabozantinib 3-Fluoro Impurity Identification Standards
Cabozantinib 3-Fluoro Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


